Home › NDC Lookup › RxCUI directory › RxCUI 580261

Tiotropium 0.018 MG Inhalation Powder [Spiriva] — RxCUI 580261

RxNorm drug concept · Semantic branded drug
RxCUI 580261 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI580261
Official nameTiotropium 0.018 MG Inhalation Powder [Spiriva]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSpiriva HandiHaler 18 MCG Inhalation Powder; Spiriva HandiHaler 18 MCG (tiotropium bromide 22.5 MCG) Inhalation Powder
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)249,767 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tiotropium Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — tiotropium is a maintenance inhaler, which means it works slowly over time to keep your airways open day to day. It won't act fast enough to help during a sudden attack. Make...
  • Can I use my tiotropium inhaler when I'm having a sudden asthma or COPD attack?
  • You'll likely notice some improvement in your breathing within the first few days of daily use. However, for asthma patients, the full benefit to your lung function may take up to...
  • How long does it take for tiotropium to start working?
📖 Read our full Tiotropium Oral Inhalation guide →

🕸️ Concept Web — How Tiotropium 0.018 MG Inhalation Powder [Spiriva] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tiotropium 0.018 MG Inhalation Powder [Spiriva] RxCUI 580261

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tiotropium 69120
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Spiriva 274535
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tiotropium Inhalation Powder 2108544
    • Tiotropium Inhalant Product 1162108
    • Tiotropium Inhalation Powder [Spiriva] 2108546
    • Spiriva Inhalant Product 1177261
    • Inhalation Powder 317000
    • Inhalant Product 1151123
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Tiotropium 0.018 MG [Spiriva] SBDC · 1799463
  • Tiotropium Inhalation Powder [Spiriva] SBDF · 2108546
  • Spiriva Inhalant Product SBDG · 1177261
  • Spiriva BN · 274535

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 580261 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0075-41 3 BLISTER PACK in 1 CARTON (0597-0075-41) / 10 CAPSULE in 1... Spiriva HandiHaler Boehringer Ingelheim Pharmaceuticals, Inc. 2005-10-11
00597-0075-47 9 BLISTER PACK in 1 CARTON (0597-0075-47) / 10 CAPSULE in 1... Spiriva HandiHaler Boehringer Ingelheim Pharmaceuticals, Inc. 2005-10-11
00597-0075-75 1 BLISTER PACK in 1 CARTON (0597-0075-75) / 5 CAPSULE in 1... Spiriva HandiHaler Boehringer Ingelheim Pharmaceuticals, Inc. 2005-10-11
50090-4248-00 3 BLISTER PACK in 1 CARTON (50090-4248-0) / 10 CAPSULE in 1... Spiriva HandiHaler A-S Medication Solutions 2019-04-02
50090-7645-00 3 BLISTER PACK in 1 CARTON (50090-7645-0) / 10 CAPSULE in 1... Spiriva HandiHaler A-S Medication Solutions 2025-08-29
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (3) · A-S Medication Solutions (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$10.6222
Range $10.6216–$11.6895 · middle 50% $10.6219–$11.1559 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.